GSK plc - Significant Ownership

Signature - Title
/s/ Victoria A. Whyte - Victoria A. Whyte, Authorized Signatory
Location
London, United Kingdom
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by GSK plc.

Email me when GSK plc files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of GSK plc

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SPRO SPERO THERAPEUTICS, INC. Common Stock, Par Value $0.001 16.4% $6.62M 9.19M GSK PLC Mar 27, 2025
CVAC CureVac N.V. Common Shares, par value (euro) 0.12 per share 0% $0 -$87.9M 0 -100% GSK plc Dec 3, 2025

Schedules 13D/G Reported by GSK plc:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.